A61P 27 - Drugs for disorders of the senses

Patents for A61P 27 - Drugs for disorders of the senses (53,017)
11/2002
11/05/2002	US6476026 Compounds and compositions as protease inhibitors
11/05/2002	US6476025 Phenylphennanthridines with PDE-IV inhibiting activity
11/05/2002	US6476022 Oxathiepino[6,5-b]dihydropyridines, and related compositions and methods
11/05/2002	US6476020 Imidazo-benzazepine compounds, their compositions and uses
11/05/2002	US6476010 Orally administering to a post-menopausal woman a fat soluble vitamin and a fat soluble vitamin absorption increasing effective amount of l-carnitine or salts
11/05/2002	US6475724 Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
11/05/2002	US6475508 Methods and pharmaceutical compositions for the closure of retinal breaks
11/04/2002	WO2004001058A2 Transcription factor modulating compounds and methods of use thereof
10/2002
10/31/2002	WO2002086087A2 Cytokine protein family
10/31/2002	WO2002086078A2 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
10/31/2002	WO2002086069A2 Secreted proteins
10/31/2002	WO2002085930A2 Immunomodulating agents from parasitic worms and method for isolation thereof
10/31/2002	WO2002085928A2 Modified cyclosporine which can be used as a pro-drug and use thereof
10/31/2002	WO2002085910A1 Polymorph forms of n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2- oxopyrrolidin -1 -yl)acetamide
10/31/2002	WO2002085906A2 Phthalazinones derivatives useful as pde4/7 inhibitors
10/31/2002	WO2002085899A1 Heterocyclyldicarbamides as caspase inhibitors
10/31/2002	WO2002085897A1 Heterocyclic compounds for aging-related and diabetic vascular complications
10/31/2002	WO2002085894A1 Arylindenopyridines with pde inhibiting activity
10/31/2002	WO2002085888A1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same
10/31/2002	WO2002085886A2 Chiral, broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions
10/31/2002	WO2002085859A1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS
10/31/2002	WO2002085414A2 Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
10/31/2002	WO2002085392A1 Method for using puerariae radix, puerariae radix flavone extract and preparation containing puerarin in the prevention and treatment of new indications
10/31/2002	WO2002085387A2 A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent ans their use in the treatment of inflammatory skin conditions
10/31/2002	WO2002085386A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue
10/31/2002	WO2002085385A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of diseases of the mucosa
10/31/2002	WO2002085384A2 Lubricious coatings for substrates
10/31/2002	WO2002085372A1 Medicines and medicinal kits
10/31/2002	WO2002085361A1 Benzimidazolone compounds
10/31/2002	WO2002085359A1 Agent for topical ophthalmic treatment of ocular inflammatory diseases
10/31/2002	WO2002085357A1 Nociceptin analogs
10/31/2002	WO2002085354A1 Spiroindene and spiroindane compounds
10/31/2002	WO2002085299A2 Therapeutic treatments using the direct application of antimicrobial metal compositions
10/31/2002	WO2002085248A2 Prostanoids augment ocular drug penetration
10/31/2002	WO2002068381A3 Aryl-n-cyanoguanidines and methods related thereto
10/31/2002	WO2002049650A3 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives
10/31/2002	WO2002041896A3 Use of thienopyrimidines
10/31/2002	WO2002022611A3 Caspase inhibitors and uses thereof
10/31/2002	WO2002004002A3 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals
10/31/2002	WO2000062766A3 Uses of ppar-gamma agonists in neutrophil-induced diseases
10/31/2002	US20020161437 Crystalline polymeric compositions for ophthalmic devices
10/31/2002	US20020161033 Substituted 1,5-dihydropyrrol-2-one derivatives active as NMDA receptor antagonists for treatment of states of pain
10/31/2002	US20020161024 Administering 2-(piperidin-2,6-dion-3-yl),4-amino-isoindolin-1-one to treat an eye condition
10/31/2002	US20020161015 Acylurea containing quinazoline derivatives
10/31/2002	US20020161014 Purinyl substituted quinazoline-4-one derivatives
10/31/2002	US20020161006 1,4-dihydropyridine compounds as bradykinin antagonists
10/31/2002	US20020160993 Method for treating glaucoma IC
10/31/2002	US20020160992 Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts
10/31/2002	US20020160987 Novel 4-dedimethylaminotetracycline derivatives
10/31/2002	US20020160984 For example, 2,3-dihydro-1H-benz(de)isoquinolin-1-one; treating diabetes, cancer, radiosensitizing tumor cells, cardiovascular disorders, septic shock, inflammatory bowel disease, senescent cells
10/31/2002	US20020160948 Such as preventing or treating primary cancer cell growth
10/31/2002	US20020160940 Modulation of endogenous gene expression in cells
10/31/2002	US20020160481 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof
10/31/2002	US20020160015 Chemokine receptor able to bind to MCP-1, MIP-1 alpha and/or rantes and its uses
10/31/2002	US20020160003 Antibody antagonists of VE-cadherin without adverse effects on vascular permeability
10/31/2002	DE10120605A1 Behandlung von Retina- oder Photorezeptor-Degenerationserkrankungen Treatment of retinal photoreceptor degeneration or disease
10/31/2002	CA2445888A1 Chiral, broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions
10/31/2002	CA2445740A1 Use of metals to treat inflammatory skin conditions
10/31/2002	CA2445734A1 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue
10/31/2002	CA2445729A1 Use of metals to treat mucosal membranes
10/31/2002	CA2445508A1 Agent for topical ophthalmic treatment of ocular inflammatory diseases
10/31/2002	CA2445233A1 Phthalazinones derivatives useful as pde4/7 inhibitors
10/31/2002	CA2445188A1 Arylindenopyridines with pde inhibiting activity
10/31/2002	CA2444675A1 Secreted proteins
10/31/2002	CA2443937A1 Prostanoids augment ocular drug penetration
10/31/2002	CA2443600A1 Heterocyclyldicarbamides as caspase inhibitors
10/31/2002	CA2443587A1 Therapeutic treatments using the direct application of antimicrobial metal compositions
10/30/2002	EP1252895A1 Remedies for ophthalmic diseases
10/30/2002	EP1252894A1 Use of agt and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions
10/30/2002	EP1252333A2 Methods and materials relating to cd84-like polypeptides and polynucleotides
10/30/2002	EP1252298A2 Phosphodiesterases
10/30/2002	EP1252158A1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes
10/30/2002	EP1252157A1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
10/30/2002	EP1252154A1 Heterocyclic amide derivatives
10/30/2002	EP1252144A1 Substituted glutarimides and use thereof il-12 production inhibitors
10/30/2002	EP1252143A1 Method for preparing alpha-sulfonyl hydroxamic acid derivatives
10/30/2002	EP1251862A1 Ophthalmic compositions for treating ocular hypertension
10/30/2002	EP1251826A1 Diclofenamide suspension gel
10/30/2002	EP0726911B1 Treatment of hematologic disorders with a igf-1/igfbp-3 complex
10/30/2002	EP0695187B1 Inhibition, control and regression of angiogenesis with hyaluronic acid or hyaluronic acid and nsaid
10/30/2002	CN1377415A 疫苗组合物 Vaccine composition
10/30/2002	CN1377347A 药学活性磺酰胺衍生物 Pharmaceutically active sulfonamide derivatives
10/30/2002	CN1377346A Z-pyrazoline-5-ones
10/30/2002	CN1377277A Use of leptin in inhibition of endothelial cell proliferation
10/30/2002	CN1377271A Use of thienopyrimidines
10/30/2002	CN1377268A Cell adhesion inhibitors
10/30/2002	CN1376504A Intravenous injection of Chinese angelica root and its preparing process
10/30/2002	CN1376463A Inclusion compound of disulfiram as eye drops and its preparing process
10/30/2002	CA2383469A1 Treatment of t-cell mediated diseases
10/29/2002	US6472412 Compounds as PDE IV and TNF inhibitors
10/29/2002	US6472400 Advanced gylcation end-product intermediaries and post-Amadori inhibition
10/29/2002	US6472396 Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds
10/29/2002	US6472379 Angiogenesis inhibition
10/29/2002	US6472165 Modulatory binding site in potassium channels for screening and finding new active ingredients
10/24/2002	WO2002083950A1 Methods and compositions for treating cardiovascular disease using 10218
10/24/2002	WO2002083926A2 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
10/24/2002	WO2002083873A2 Enzymes
10/24/2002	WO2002083716A2 Type b botulism toxin inhibitors
10/24/2002	WO2002083712A2 Transporters and ion channels
10/24/2002	WO2002083709A2 Kinases and phosphatases

1 ... 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 ... 531